The authors studied the effects of a standardized mild-moderate hypoglycemic stimulus (glucose clamp) on brain functional magnetic resonance imaging (fMRI) responses to median nerve stimulation in anesthetized rats. In the baseline period (plasma glucose 6.6 ± 0.3 mmoIlL), the MR signal changes induced by median nerve activation were determined within a fixed region of the somatosensory cortex from prein fusion activation maps. Subsequently, insulin and a variable glucose infusion were administered to decrease plasma glucose. The goal was to produce a stable hypoglycemic plateau (2.8 ± 0.2 mmoUL) for 30 minutes. Thereafter, plasma glucose was restored to euglycemic levels (6.0 ± 0.3 mmoI/L). In the early phase of insulin infusion (15 to 30 minutes), before hypogly cemia was reached (4. 7 ± 0.3 mmollL), the activation signal was unchanged. However, once the hypoglycemic plateau was
Severe hypoglycemia produces profound neurologic impairments in keeping with the brain' s obligatory re quirement for glucose derived from the circulation (Sjesjo, 1988) . It is presently appreciated that even mild to moderate hypoglycemia can impair performance dur ing a variety of cognitive tasks and electrophysiologic measurements of cortical and brainstem function in hu mans (Jones et aI., 1990) . This exquisite sensitivity of the brain to mild-moderate glucose deprivation is also ob served in rodents (Weber et aI., 1994) . Relatively mild reductions in plasma glucose to 2.8 of 3 mmollL have been reported to significantly delay conduction through the auditory pathway in conscious rats using electrodes achieved, the activation signal was significantly decreased to 57 ± 6% of the preinfusion value. Control regions in the brain that were not activated showed no significant changes in MR signal intensity. Upon return to euglycemia, the activation sig nal change increased to within 10% of the original leveL No significant activation changes were noted during euglycemic hyperinsulinemic clamp experiments. The authors concluded that fMRI can detect alterations in cerebral function because of insulin-induced hypoglycemia. The signal changes observed in fMRI activation experiments were sensitive to blood glucose levels and might reflect increases in brain metabolism that are limited by substrate deprivation during hypoglycemia. Key Words: Magnetic resonance imaging-Cerebral blood t1ow Hypoglycemia-Functional activation.
implanted in the inferior colliculus region of the brain stem (Weber et aI., 1994; Jacob et aI., 1995) . Although evoked potential measurements during hypoglycemia have been useful in demonstrating impaired central ner vous system (CNS) responses, they provide little infor mation on the precise nature and localization of the CNS changes, and for many brain regions electrophysiologic responses have not been demonstrated.
The advent of neuroimaging techniques, such as pos itron emission tomography (PET) and functional mag netic resonance imaging (fMRI), has made it possible to generate high resolution maps of blood t10w and oxy genation responses to neuronal activity (Fox et aI., 1988; Kwong et aI., 1992) . The blood oxygen level-dependent (BOLD) contrast, depicted by MRI, has been a subject of great interest since Ogawa et a1. (1990) demonstrat ed that varying levels of oxygen saturation can change contrast in T 2 *-weighted images. Although these effects have been successfully exploited in the development of fMRI techniques, the relations between alterations in metabolism, cerebral hemodynamic blood oxy genation, and fMRI signal changes are not well under stood. In fMRI several factors may affect image contrast, including alterations of blood flow, blood volume, and intravascular magnetic susceptibility arising from blood hemoglobin (Kennan et aI., 1994) . In an attempt to better define the origins of the changes in fMRI signal contrast, physiologic models have been developed to relate BOLD signal changes to physiologic parameters such as blood tlow and oxidative metabolism (Buxton and Frank, 1997; van Zijl et aI., 1998; Hyder et aI., 1998 Hyder et aI., ,1999 . A com mon feature of these models of BOLD contrast is that it reflects a local increase in blood flow that accompanies increases in oxidative metabolism caused by increases in neuronal activity. This blood tlow increase overcompen sates for the local oxygen demands, leading to a relative increase in the amount of venous oxyhemoglobin and a decrease in venous deoxyhemoglobin in tissue (Roy and Sherrington, 1890) . The development of animal models for fMRI have been useful in understanding the origins of fMRI signal contrast (Hyder et aI., 1994 (Hyder et aI., , 1996 Gyngell et aI., 1996; Kennan et aI., 1998; Mandeville et al., 1998) and for new approaches for functional assess ment based on, for example, blood volume changes (Kennan et aI., 1997) and oxidative metabolism (Hyder et aI., 1996) .
Neglecting blood volume changes, the theoretical re lation between the changes in BOLD fMRI signal (S) and cerebral blood flow (CBF) and cerebral metabolic rate of oxygen consumption (CMR02) is given by Hyder et al. (1998) as
where A is a constant and il represents the difference between active and resting states (that is, ilCB F acl = CB Fac t -CB Fr es J Equation 1 reiterates that when all other parameters are fixed, the BOLD signal increases with blood flow (less venous deoxyhemoglobin) and de creases with oxygen consumption (more venous deoxy hemoglobin). The usual increase in fMRI signal during neuronal stimulation implies that blood flow changes are greater than the oxidative metabolism changes (CB Fac / CB Fr est > CMR02, a jCMR02,rest). Recent work using forepaw stimulation in the rat at 9.4T shows a linear correlation between blood flow and BOLD response (Silva et aI., 1999) .
In the normal brain, oxidative glucose metabolism consumes 4 to 6 moles of oxygen for each mole of glu cose (Fox et aI., 1988; Sokoloff, 1977; Hyder et aI., 1994) . This is somewhat lower than the theoretical limit of 6 moles oxygen per mole glucose because glucose can enter other nonoxidative pathways (Sokoloff et aI., 1977; Hyder et aI., 1994) . The coupling between glucose me tabolism and oxidative metabolism is less clear when the brain is in an active state. Early work using PET indi cated that during visual stimulation the ratio of percent metabolism increase (ilCMR02/CMR02,rest) to percent blood flow increase (ilCB F /CB Fr est) is approximately 0.1: 1 (Fox et aI., 1988) . This report concludes that the ratio of oxygen consumption to glucose consumption was 0.4: 1, which is much less than expected from the resting brain data (Fox et aI., 1988) . More recently, MR based methods in rat models (Kida et aI., 1999) and human studies (Hoge et aI., 1999) indicate significantly larger changes in oxidative metabolism during periods of increased neuronal activity. For example, Kida et al. (1999) show that when brain activity is altered through anesthetics in the rat, the ratio of percent oxidative me tabolism changes to percent blood flow changes is ap proximately 0.8: 1, whereas the work of Hoge et al. gives a ratio of 0.5: 1 in the human brain during visual stimu lation. Thus, during periods of increased neuronal activ ity there is greater oxidative metabolism, which in turn relies on glucose metabolism. The goal of the current work is to investigate in an animal model of activation whether fMRI can detect changes in the BOLD response to forepaw stimulation during mild hypoglycemia that may serve as signatures of functional impairment caused by decrements in glucose delivery to the brain.
MATERIALS AND METHODS

Animal model
Healthy female Sprague Dawley rats weighing 25 0 to 360 g were initially anesthetized with 0.8 % halothane, then trache otomized, and artificially ventilated using oxygen:nitrogen mixtures (40:60). Throughout, the rats lied supine on a hot water blanket to maintain body temperature. A venous catheter was inserted into the tail vein for infusion of propofol, which allowed for gradual discontinuation of halothane. The propofol infusion rate was adjusted slowly, depending upon respiratory rate and the level of responsiveness to footpad pinch. During the acquisitions, the infusion rate ranged from 0.21 to 0.35 mg/kg·min. Three additional catheters were placed to infuse glucose and insulin solutions (femoral vein), to draw blood samples and monitor blood pressure (femoral artery), and to administer a paralytic agent, tubocurarine chloride (intraperi toneal). Two needle electrodes were inserted subdermally at the wrist, proximal to the footpads of either the left or right fore paw in random order. Median nerve stimulation was applied as a square wave (positive only) using a Tektronix 2620 constant current stimulus isolator (6 Hz with a stimulus duration of 0.3 milliseconds). This stimulus intensity was sufficient to elicit partial contraction of the forepaw, which varied from 2 to 3 rnA. Blood gases were monitored hourly to ensure relatively stable levels of oxygen (> 120 mm) and carbon dioxide (maxi mum range of 28 to 44 mm over the course of the experiment). Blood pressure and heart rate were monitored through the femoral artery catheter. Further details of the animal model are described elsewhere (Scanley et aI., 1997 ) .
Magnetic resonance imaging
All studies were performed at 2.0T on a GE CSIIOmega imaging system. Images were obtained using a I-cm diameter surface coil placed under the head. Horizontal scout images were first acquired parallel to the dorsal surface of the cerebral hemispheres (Zillies, 198 5) , and from these sections were pre scribed through cortex approximately 0.5 to 1.0 mm deep. Functional MRI images were obtained using a spoiled GRASS sequence with a FOY of 40 mm, and a slice thickness of I mm. The repetition time (TR) was 100 milliseconds, and the echo time (TE) was 30 milliseconds. High resolution anatomic 64 x 128 images were obtained with 2 averages, whereas lower reso lution 32 x 64 images (zerofilled to 64 x 64 pixels with inplane resolution of 0.63 x 0.63 mm) were obtained with 4 averages such that the total time per image was 12 seconds. The lower resolution images were used for all euglycemia and hypogly cemia evaluations because they had an intrinsically higher sig nal-to-noise (over 200:1 at TE = 30 milliseconds). Images were acquired continuously for an alternating stimulus pattern of two images "off' and two images "on". Image sets were acquired with 32 images per set.
Insulin clamp and activation protocol
After the insertion of catheters and electrode placement, all animals were allowed to equilibrate for 60 minutes. Thereafter, a series of preinfusion forepaw stimulations and fMRI mea surements were conducted. Those animals with cardiac param eters, plasma glucose, and tMRI that were within normal limits at baseline were then used in the following two protocols. Both groups received a 20 mU/kg·min infusion of Regular human insulin (Humalin R, Eli Lilly, Indianapolis, IN, U.S.A.) starting at t = O. In the first group (n = 6), plasma glucose concen tration was allowed to decline over a period of -20 minutes. Plasma glucose was then maintained at 2.8 to 3.0 mmollL for an additional 20 to 40 minutes using a variable dextrose infu sion that was adjusted based on 10 minutes blood glucose mea surements. Forepaw stimulation and tMRI were performed in the intervals between blood sampling (3 x 10 minutes). After wards, the dextrose infusion was increased to restore plasma glucose levels to baseline levels for 30 minutes while fMRI data were acquired. In group 2 (n = 5), plasma glucose values were clamped at baseline levels using a variable glucose infu sion throughout a 60-minute insulin infusion, whereas the same fMRI stimulus was performed. To prevent hemodynamic changes caused by blood loss, donor blood was given to replace sample volumes.
Data analysis
Parametric t-maps. Scans were analyzed to generate statis tical parametric activation maps based on the Student's {-test. A t-statistic was computed for each pixel in the image by com paring the signal values measured without stimulation to those measured during stimulation. The activated region was defined as the largest contiguous cluster of pixels with t values greater than 2 that occurred within cortex. A contiguous cluster was defined as pixels either connected by edges or by corners. In all cases this occurred in the forepaw region of the somatosensory cortex contralateral to the median nerve stimulus.
Region of interest analysis. To quantify the changes in activation signal caused by altered blood glucose levels, a fixed region of interest (ROI) analysis was used for each animal. The initial activation data were analyzed to detect regions showing significant activation (Student's t value> 2). A 3 x 3 pixel ROI was then drawn within the activated region of the somatosen sory cortex as determined from the preinfusion activation maps. It was positioned in the center of the activated region in the horizontal images, approximately 5 mm caudal to the most rostral aspect of the rhinal fissure. A typical activation map overlaid on a high resolution horizontal spoiled-GRASS rat brain image is illustrated in Fig. I A. Figure I B shows the corresponding time course of the fMRI signal during neuronal stimulation for the activated region using the stimulus protocol described above. Activation was quantified by measuring the mean signal change, .6.S, between nonstimulation and stimula tion images within the fixed region. All activation parameter values (.6.S) during infusion were then normalized by the pre infusion values for each animal. This normalization procedure removed animal to animal variations in the blood flow response to stimulation and isolated the relative effects because of al tered plasma glucose in each animal. To check for global signal changes in the rat brain that could be mediated by changes in total cerebral blood flow during hypoglycemia, a control ROI was set in an ipsilateral cortical region that showed no signifi cant response to median nerve stimulation ( Fig. I A) . The signal in this region was then monitored throughout the infusion pe riod. Data were grouped according to blood glucose levels for comparison as discussed below.
RESULTS
The mean signal increase for the contralateral ROI (as shown in Fig. lA ) caused by neuronal stimulation during the baseline period was ilSo/S = 0.03 ± 0.0 1, with a TE of 30 milliseconds, a response similar to that previously reported in the anesthetized rat at this magnetic field strength (Scanley et aI., 1997) . When insulin was in fused, the decrement in plasma glucose was accompa nied by a decrease in activation signal relative to the preinfusion state. Restoration of euglycemia almost en tirely restored the activation response. This is illustrated in a single animal in Fig. 2A that shows activation maps overlaid on long TE anatomic images (those used for generating the activation map) during 3 sequential por tions of the study, that is, plasma at 5.7 mmollL, 2.9 mmollL, and 5.2 mmol/L, respectively, The maps shown are thresholded to the same level of significance (P < 0.04) to illustrate the effect of lowered plasma glucose, Figure 2B shows the corresponding temporal evolution of the fMRI signal intensity and blood glucose, Figure 3 summarizes the results of the ROI analysis during neuronal stimulation for the hypoglycemia studies (n = 6 rats, with a total of 64 stimulation sets). At baseline, the blood plasma glucose averaged 6.6 ± 0.3 mmol/L and was always above 5.2 mmol/L. During the insulin infusion period, the data were grouped as fol lows: (I) the prehypoglycemia phase, that is, plasma glu cose >4 mmol/L (mean = 4.7 ± 0.2 mmollL); (2) the jMRI RESPONSE TO MEDIAN NERVE STIMULA TION /355 '"d (l) .� - hypoglycemia phase (mean = 2.8 ± 0.2 mmoI/L); and (3) the euglycemic restoration period at which time the glucose was >4 mmol/L (mean = 5.9 ± 0.3 mmoIlL). Data at intermediate glucose levels between 3.6 mmollL and 4 mmollL were discarded from analysis. Table I shows the stability of physiologic parameters over the course of the experiment. In general, there was a small drift of decreasing blood pressure and increasing arterial
Peo2. These changes were not correlated with blood glu cose. Figure 3 shows the mean signal change (�S) during neuronal stimulation for the contralateral somatosensory ROI normalized to the preinfusion value (AS p reinf)' In the prehypoglycemia phase (group I), there was no signifi cant reduction in activation signal as compared with the preinfusion state. However, when plasma glucose was reduced to less than 3.6 mmol/L during the hypoglyce mia phase, the activation signal was 43% less than the .• a ..
A 5.7 mmoIlL B 2.9 mmoIlL C 5.2 mmoIlL preinfusion value, a difference that was highly signifi cant (P < 0.0005). Restoration of euglycemia caused a rapid increase in the activation intensity (P < 0.0005) that slightly, but not significantly, overshot the basal intensity by 10%. These results are summarized in Table 2 . Changes in the intensity of the activation signal induced by changes in plasma glucose levels were relatively rapid; the lag was generally less than 20 minutes. Figure  4 shows the result of ROI analysis in the control region throughout the hypoglycemia infusion study. There were small changes in global cerebral oxygenation (and hence, blood flow and metabolism) in the brain before, during, and after hypoglycemia was produced. Although the mean changes during hypoglycemia « 0.3%) were in significant (P < 0.5), those during the recovery period showed an increase of 1.3% relative to the preinfusion signal that approached statistical significance (P < 0.07). This signal increase during recovery might be because of reactive hyperemia as the glucose infusion rate was in creased. Figure 5 and Table 3 show the cumulative results in the euglycemic control animals (n = 5 rats). Six stimu lation data sets were evaluated for each animal over the course of 60 to 90 minutes. After the preinfusion period (plasma glucose, 7.42 ± 0.4 mmollL), 6 stimulation data sets were evaluated during the euglycemic hyperinsu linemia (mean plasma glucose of 6.5 ± 0.5 mmol/L). Data were grouped sequentially in 20-minute periods. There was a small but insignificant (P < 0. 15) decrease in the activation signal in the initial 10 to 20 minutes of euglycemic hyperinsulinemia, but no significant changes occurred thereafter. Thus, although there may be some temporal degradation of the activation-related signal during the infusion, there was no evidence of temporal fluctuations that could account for the changes observed during the hypoglycemic clamp study.
DISCUSSION
The current study demonstrated that during mild, con trolled hypoglycemia the fMRI response caused by me dian nerve stimulation was significantly decreased. This hypoglycemia-induced change was rapidly reversed when euglycemia was restored. Although small but in significant changes in the tMRI signal were associated with euglycemic hyperinsulinemia, this cannot account for the response changes observed during hypoglycemia . Furthermore, there were no apparent signal changes dur ing the hypoglycemic episode within a control brain re gion not involved in activation. Although previous fMRI studies have shown that hyperglycemia had little effect on visual stimulation response (Gruetter et aI., 1997) , to the authors' knowledge there have been no reported re sults on the effects of hypoglycemia on fMRI.
Several potential effects of hypoglycemia must be considered to explain the observed changes in the fMRI response. Equation I shows that the BOLD signal change is proportional to the fractional change in blood flow and oxidative metabolism during activation. Four possible scenarios that could explain a decrease in BOLD re sponse during hypoglycemia are summarized below. These four cases can be grouped as changes in flow metabolism of the resting state (while the active state is unaffected by hypoglycemia) and changes in the flow metabolism coupling in the active (rest + �) state.
First, if this degree of hypoglycemia was sufficient to produce an increase in brain blood flow, or vasodilation, or both, then the additional effects of neuronal activation could have been attenuated, leading to a reduced BOLD effect by virtue of an increase in the term CBFrcst in Eq. 1. This mechanism is, for example, the explanation for the reduction in BOLD signals seen during CO2 admin istration (Bandettini et aI., 1995) . The authors believe this possibility is however unlikely for their observations during hypoglycemia. No global changes in the MRI signal were observed during hypoglycemia in keeping with several reports demonstrating no changes in cere bral flow during mild hypoglycemia of a similar degree in humans (Powers et aI., 1993) and rodents (Hornika et aI., 1997) . However, it should be emphasized that more severe hypoglycemia (mean plasma glucose of < 2.0 mmol/L) does significantly increase blood flow in hu mans as observed by single photon emission computed tomography techniques (Tallroth et aI., 1992 (Tallroth et aI., , 1993 . Thus, the presence of global blood flow changes cannot be completely excluded because simultaneous blood flow measurements were not performed. Unfortunately, the authors were unable to perform such measurements with sufficient signal-to-noise at 2.0T, though this may be possible at higher field strengths or with customized coil designs.
1.2
rJJ. The x-axis denotes mean blood glucose level as discussed in the text (20 minutes, CplGIU = 6.6 ± 0.7 mmol/L; 40 minutes, CplGIU = 6.5 ± 0.2 mmol/L; 60 minutes, CplGIU = 6.55 ± 0.3 mmoI/L). The y-axis denotes the mean signal change, �S, for ROI during neu ronal stimulation, �sac" normalized to the preinfusion mean sig nal change during neuronal stimulation, �so ac t , during 60 to 90 minutes clamp. Mean data are grouped consecutively (-20 to 30 minutes per group) with two activation sets per group.
Second, if the basal oxidative metabolism decreased during hypoglycemia (CMR02.rest decreases), the au thors would expect a decrease in the BOLD response in Eq. 1. Such a global decrease in metabolism should also cause an increase in the resting signal during hypogly cemia that the authors did not detect. Alternatively, hy poglycemia could have decreased the BOLD effect if the flow, or metabolism, or both, in the active state were altered. A decrease in BOLD signal could be accounted for if oxygen use in the activated state was stimulated (�CMR02 .act increases during hypoglycemia), thereby maintaining higher levels of deoxyhemoglobin. How ever, this is highly unlikely given the presence of glucose deficiency, thereby requiring an alteration of the stoichi ometry of oxidative metabolism. Finally, a decrease in the blood flow response to neuronal stimulation (�CB Fact decreases) might have occurred that would decrease the activation signal. The degree by which local oxida tive metabolism can increase upon stimulation is itself likely to be limited by the reduced availability of glucose from the circulation. Although the mechanism underly ing the link between limited glucose availability, im paired oxidative metabolism, and the local blood flow response remains uncertain; the authors favor the last scenario because they did not observe resting signal changes during hypoglycemia, and it is unlikely that me tabolism in the active state would increase during hypo glycemia. It is also possible that some combination of these effects could lead to the observed response. Future studies using quantitative flow tMRI (Schwarzbauer et aI., 1996; Kim and Tsekos, 1997) , quantitative blood volume fMRI (Kennan et aI., 1997 (Kennan et aI., , 1998 Mandeville et aI., 1998) , and near infrared spectroscopy (Maki et aI., 1995; Obrig et aI., 1996) may clarify the interpretation of the data.
It should be noted that a previous study using PET to monitor the motor activation blood flow response in hu mans showed no significant effect when plasma glucose was decreased to similar hypoglycemic levels (Powers et aI., 1996) . It is most likely that differences between these findings and those reported in the current are because of the type of stimulus used. The much more intense 6 Hz electrical stimulus used in the current study is likely to invoke greater metabolic changes in the brain than the motor task involving finger tapping used in that previous study. Functional magnetic resonance imaging might also have provided increased sensitivity because of high spatial resolution that allow the detection of small local ized activation regions, which may be averaged out in PET. Other possible explanations include an indirect coupling of the effects of blood glucose to the level of anesthesia; however, the authors did not note any sys tematic changes in blood pressure or heart rate during hypoglycemic episodes. Alternately, there simply could be a basic physiologic difference between the metabolic responses of the rat brain and the human brain. However, previous studies in rat models have shown similar effects of hypoglycemia on neurologic function as measured electrophysiologically and observed in humans (Jacob et aI., 1995) . Also, the authors observed changes in the activation signal within 20 to 30 minutes of establishing mild hypoglycemic conditions. This was significantly faster than when observed through electrophysiology (Jacob et aI., 1995) , thus it may be possible that the J Cereh Blood Flow Metab. Vol. 20. No. 9. 2000 coupling mechanism between blood flow and metabolic demand is affected before the deterioration of neuronal response.
In summary, the authors have found that tMRI can detect dynamic changes in cerebral function because of insulin-induced mild hypoglycemia, which are reversible upon the restoration of euglycemia. The fMRI effect is localized to the region of activation and is likely not related to global changes in cerebral blood flow. The implication of these experiments is that fMRI may reflect increases in local brain glucose metabolism that under conditions of hypoglycemia may be substrate limited.
